IL-11. A type of biological response modifier (a substance that can improve the body's natural response to infection and disease) that stimulates immune response and may reduce toxicity to the gastrointestinal system resulting from cancer therapy. These substances are normally produced by the body. They are also made in the laboratory for use in treating cancer and other diseases. Also called oprelvekin.
To learn more, select a condition from the following menu.